The Definition and Measurement of Disease Modification in Inflammatory Rheumatic Diseases

Aletaha, Daniel, Smolen, Josef S.·2006·Rheumatic Disease Clinics of North America
DOI 10.1016/j.rdc.2005.09.005

Cited by (150)

Items 101–150 of 150

  1. Discordances between clinical and ultrasound measurements of disease activity among RA patients followed in real life
    Pascal Zufferey, Delphine Sophie Courvoisier, Michael John Nissen, Burkhard Möller, Laure Brulhart, Hans Ruedi Ziswiler, Giorgio Tamborrini, Adrian Ciurea, Maria Antonietta D’Agostino, Axel Finckh · 2019 · Joint Bone Spine
  2. The Patient Experienced Symptom State (PESS): a patient-reported global outcome measure that may better reflect disease remission status
    Cátia C. M. Duarte, Eduardo José Ferreira Santos, José António Pereira da Silva, Eirik Klami Kristianslund, Tore Kristian Kvien, Maxime Dougados, Maarten P. T. de Wit, Laure Gossec, Turid Heiberg · 2020 · Rheumatology
  3. Continual Maintenance of Remission Defined by the ACR/EULAR Criteria in Daily Practice Leads to Better Functional Outcomes in Patients with Rheumatoid Arthritis
    Kumi Shidara, Ayako Nakajima, Eisuke Inoue, Daisuke Hoshi, Naoki Sugimoto, Yohei Seto, Eiichi Tanaka, Shigeki Momohara, Atsuo Taniguchi, Hisashi Yamanaka · 2016 · The Journal of Rheumatology
  4. Predicting the treatment response of certolizumab for individual adult patients with rheumatoid arthritis: protocol for an individual participant data meta-analysis
    Yan Luo, Konstantina Chalkou, Ryo Yamada, Satoshi Funada, Georgia Salanti, Toshi A. Furukawa · 2020 · Systematic Reviews
  5. Effectiveness of whole-body magnetic resonance imaging for the efficacy of biologic anti-rheumatic drugs in patients with rheumatoid arthritis: A retrospective pilot study
    Michihito Kono, Tamotsu Kamishima, Shinsuke Yasuda, Keita Sakamoto, Sawako Abe, Atsushi Noguchi, Toshiyuki Watanabe, Yuka Shimizu, Kenji Oku, Toshiyuki Bohgaki et al. · 2017 · Modern Rheumatology
  6. Disease-modifying anti-nephropathic drugs (DMANDs)—a definition proposed by the Immunonephrology Working Group (IWG) of the European Renal Association (ERA)
    Y K Onno Teng, Eleni A. Frangou, Andreas Kronbichler, Annette N. Bruchfeld, Fernando Caravaca‐Fontán, Jürgen Floege, Sarah Margaret Moran, Şafak Mirioğlu, Kate Stevens, Stefanie Steiger et al. · 2025 · Nephrology Dialysis Transplantation
  7. A computational method to differentiate rheumatoid arthritis patients using thermography data
    Jolanta Pauk, Justas Trinkunas, Roma Puronaitė, Mikhaił Ihnatouski, Agnieszka Wasilewska · 2021 · Technology and Health Care
  8. Acceptable quality of life and low disease activity achievable among transition phase patients with rheumatic disease
    Heikki Relas, Silja K. Kosola · 2018 · Clinical Rheumatology
  9. Clinical joint inactivity predicts structural stability in patients with established rheumatoid arthritis
    Miriam Gärtner, Irene Katharina Sigmund, Farideh Alasti, Gabriela M. Supp, Helga Radner, Klaus Peter Machold, Josef S Smolen, Daniel Aletaha · 2016 · RMD Open
  10. Asthma remission in the context of other immune-mediated diseases
    Josef S Smolen, Bruce E. Sands, Daniel J. Jackson, Michael E. Wechsler, David J. Jackson, Praveen Akuthota, Flavia Cecilia Lega Hoyte, Ian Douglas Pavord, Rohit K. Katial, Linda Joanne Rogers · 2025 · Journal of Allergy and Clinical Immunology
  11. Infrared Thermography and Deep Learning Prototype for Early Arthritis and Arthrosis Diagnosis: Design, Clinical Validation, and Comparative Analysis
    Francisco Jacob Ávila-Camacho, Leonardo Miguel Moreno-Villalba, José Luis Cortes-Altamirano, Alfonso Alfaro-Rodríguez, Hugo Nathanael Lara Figueroa, María Elizabeth Herrera-López, Pablo Romero-Morelos · 2025 · Technologies
  12. Doubtful swelling on clinical examination reflects synovitis in rheumatoid arthritis
    Péter Mandl, Paul Studenic, Gabriela M. Supp, Martina Durechova, Stefanie Haider, Michaela Lehner, Tanja Stamm, Josef S Smolen, Daniel Aletaha · 2020 · Therapeutic Advances in Musculoskeletal Disease
  13. Patient access to rheumatoid arthritis treatments
    Bengt Jönsson · 2007 · The European Journal of Health Economics
  14. Defining Disease Modification in IgA Nephropathy: Toward a Paradigm Shift in Management
    Jonathan Barratt, Laura H. Mariani, Jai Radhakrishnan, Dana V. Rizk, James Alan Tumlin, Richard A. Lafayette · 2025 · Kidney International Reports
  15. Patients with psychiatric diagnoses have lower quality of life than other patients with juvenile rheumatic disease: a prospective study
    Silja K. Kosola, Heikki Relas · 2021 · Rheumatology
  16. Structural disease modification in axial spondyloarthritis
    Brona Dinneen, Finbar D. O'Shea, Lianne S. Gensler · 2023 · Best Practice & Research Clinical Rheumatology
  17. Evaluation and outcomes of patients with rheumatoid arthritis
    Daniel Aletaha, Josef S Smolen · 2015 · Elsevier eBooks
  18. Treatment Response to Tumor Necrosis Factor Inhibitors and Methotrexate Monotherapy in Adults With Juvenile Idiopathic Arthritis: Data From NOR-DMARD
    Imane Bardan, Karen Minde Fagerli, Joe Sexton, Tore Kristian Kvien, Gunnstein Bakland, Paweł Mielnik, Yi Hu, Gunhild Lien, Berit Flatø, Øyvind Molberg et al. · 2022 · The Journal of Rheumatology
  19. Radiographic progression in axial spondyloarthritis: Is it the expression of a helpful measure of structural involvement outcome?
    Wilson Bautista‐Molano · 2018 · Revista Colombiana de Reumatología (English Edition)
  20. Etanercept in moderate rheumatoid arthritis: PRESERVE study results from central/eastern Europe, Latin America and Asia
    Karel Pavelká, Rubén Burgos‐Vargas, Pedro Miranda, Renato Guzmán, Jeng‐Hsien Yen, Mustafa Al Izzi, Zoltán Szekanecz, Boxiong Tang, Annette E. Szumski, Sameer V. Kotak et al. · 2014 · International Journal of Clinical Rheumatology
  21. Disease-modifying effect of etanercept versus sulphasalazine on spinal mobility in patients with ankylosing spondylitis
    Suzanne B. Hendrix, Andrew S. Koenig, Wenzhi Li, Amitabh Singh · 2013 · Journal of International Medical Research
  22. Tapering and discontinuation of oral glucocorticoids without deterioration of disease status in patients with rheumatoid arthritis under a stable treatment
    Shintaro Hirata, Hiroki Kohno, Hirofumi Watanabe, Tadahiro Tokunaga, Yusuke Yoshida, Tomohiro Sugimoto, Sho Mokuda, Keisuke Oda, Takaki Nojima, Eiji Sugiyama · 2020 · Modern Rheumatology
  23. Quality of life and disease activity of patients with rheumatoid arthritis on tofacitinib and biologic disease-modifying antirheumatic drug therapies
    Vladimira Vasileva Boyadzhieva, Konstantin Tachkov, Nikolay Rumenov Stoilov, Konstantin Mitov, Rumen Malinov Stoilov, Guenka Ivanova Petrova · 2022 · Rheumatology International
  24. Estimating Patient-Specific Relative Benefit of Adding Biologics to Conventional Rheumatoid Arthritis Treatment
    Yan Luo, Konstantina Chalkou, Satoshi Funada, Georgia Salanti, Toshi A. Furukawa · 2023 · JAMA Network Open
  25. Association between periodontitis and the risk of inadequate disease control in patients with rheumatoid arthritis under biological treatment
    Hsin‐Hua Chen, Der‐Yuan Chen, Liang‐Gie Huang, Yi‐Ming Chen, Chia‐Wei Hsieh, Wei‐Ting Hung, Kuo‐Tung Tang, Gin Chen · 2019 · Journal Of Clinical Periodontology
  26. Predictive clinical factors in rheumatoid arthritis using disease activity and functional score
    Worakan Tipsing, Kittisak Sawanyawisuth · 2021 · Reumatologia/Rheumatology
  27. Artritis reumatoide en el paciente mayor
    Jorge Alberto Barragán Garfias · 2011 · Acta Médica Grupo Ángeles
  28. Evaluation and outcomes of patients with rheumatoid arthritis
    Daniel Aletaha, Josef S Smolen · 2011 · Elsevier eBooks
  29. Clinimetría, una herramienta indispensable
    José Francisco Díaz-Coto, Pablo Monge-Zeledón · 2011 · DOAJ (DOAJ: Directory of Open Access Journals)
  30. Definition and application of systemic lupus erythematosus disease modification in emerging markets: Delphi panel consensus recommendations
    Guillermo Pons‐Estel, Odirlei André Monticielo, Edgard Torres dos Reis-Neto, Juan Manuel Mejia-Vilet, Ibrahim Abdulrazag Al-Homood, Reem Al-Jayyousi, Luciana Parente Costa Seguro, Suzan Mansour Attar, Mercedes García, Alejandra Magdalena Babini et al. · 2025 · Lupus
  31. Rheumatoid Arthritis in Adults
    Josef S Smolen, Andreas Kerschbaumer, Daniel Aletaha, William H. Robinson · 2026 · JAMA
  32. Metacarpophalangeal and wrist MRI bone marrow edema can reflect the disease activity of rheumatoid arthritis and correlate with SDAI, CDAI and DAS28.
    Bo Chen, Lei Zhang, Weina Guo, Jie Han, Xiao‐Qing Yang, Peichen Shen, Wenjian Xu, Ning Li · 2016 · Biomedical Research-tokyo
  33. Disease activity assessment in rheumatoid arthritis
    Josef S Smolen · 2020 · Oxford University Press eBooks
  34. Articular18Fluorodeoxyglucose Uptake Is Associated With Clinically Assessed Swollen Joint Count in Patients With Rheumatoid Arthritis
    Iván Ferraz‐Amaro, Arif Sheikh, Berna Polack, Jon T. Giles, Joan M. Bathon · 2022 · The Journal of Rheumatology
  35. Development and Evaluation of Disease Activity Measures in Rheumatoid Arthritis Using Multi-Level Mixed Modeling and Other Statistical Methodologies: A Dissertation
    Mary Jane Bentley · 2010 · eScholarship@UMassChan
  36. Clinical Disease Activity and Radiological Damage in Early Rheumatoid Arthritis
    Keeranur Jayakumar · 2010 · University of Hertfordshire Research Archive (University of Hertfordshire)
  37. The role of X-ray imaging and musculoskeletal ultrasound in the diagnosis and management of rheumatoid arthritis
    Hamed Rezaei · 2014 · Figshare
  38. SAT0143 Analysis of Patients Who Obtained Remission by Disease Activity Score After Tocilizumab Treatment But Still had Low Disease Activity by Clinical Disease Activity Index, and Examination of Points for Treatment Intensification
    Yuichiro Yabe, Toshihisa Kojima, Atsushi Kaneko, Y. Kanayama, Yuji Hirano, Tomone Shioura, Kiwamu Saito, N. Asai, Tomonori Kobayakawa, Naoki Ishiguro · 2013 · Annals of the Rheumatic Diseases
  39. How Do We Evaluate an Inadequate Response in a Patient With Rheumatoid Arthritis in the Clinical Praxis?
    Alejandro Balsa · 2007 · Reumatología Clínica (English Edition)
  40. Combination of High-Molecular-Weight Hyaluronic Acid and Cytokine Inhibitor Potently Inhibits Expression of Joint-Damage-Related Genes Induced By Synovial Fluid of RA Patients
    Misato Hashizume · 2014 · Journal of Arthritis
  41. Early rheumatoid arthritis aspects of severity and co-morbidity
    Lena Innala · 2014 · DiVA at Umeå University (Umeå University)
  42. Biologic Therapies In Rheumatoid Arthritis
    Mark Houseman, John Dudley Isaacs · 2009 · CRC Press eBooks
  43. Reumatología Clinimetría, una herramienta indispensable
    José Francisco Díaz-Coto, Pablo Monge-Zeledón · 2011
  44. Progresión radiográfica en espondiloartritis axial: ¿es el reflejo de una medida útil de desenlace de compromiso estructural?
    Wilson Bautista‐Molano · 2018 · Revista Colombiana de Reumatología
  45. Divergences entre les évaluations cliniques et échographiques de l’activité de la maladie chez des patients atteints de PR suivis en situation réelle
    Pascal Zufferey, Delphine Sophie Courvoisier, Michael John Nissen, Burkhard Möller, Laure Brulhart, Hans Ruedi Ziswiler, Giorgio Tamborrini, Adrian Ciurea, Maria Antonietta D’Agostino, Axel Finckh · 2020 · Revue du Rhumatisme
  46. Can imaging help unravel pain in psoriatic arthritis?
    Irina Gessl, Daniel Aletaha, Péter Mandl · 2021 · Rheumatology
  47. The Adaption and Validation Processes in Remission Criteria for Rheumatoid Arthritis
    Paul Studenic · 2023 · touchREVIEWS in RMD
  48. Telemonitoring disease activity with electronic patient reported outcomes in patients with inflammatory arthritis
    Jimmy Wiegel · 2023
  49. Real-world inflammatory bowel disease-modification outcomes: A narrative review
    Neeraj Narula, Shashi Adsul, Walter Reinisch · 2026 · World Journal of Gastroenterology
  50. Disease modification outcomes in type 2 diabetes: a modified Delphi
    Kamlesh K. Khunti, Mark P. Funnell, PATRICK J. HIGHTON, Ashkon Ardavani, Javed Butler, Jon Campbell, Melanie Jane Davies, Rachel Evley, José C. Florez, Jason L. Gaglia et al. · 2026 · The Lancet Diabetes & Endocrinology